Our Amicus Briefs | Biosimilars & Generics | AAM

In the News - View AAM CEO Dan Leonard's blog on the essential role generic drugs play during COVID-19

The Association for Accessible Medicines and its Biosimilars Council advocates in state and federal courts to support patient access to affordable generic and biosimilar medicines. We file amicus briefs in litigation that affects the ability of our members to deliver such medicines to patients in need. Below you will find recent amicus briefs that AAM has filed on behalf of our member companies.

AAM Amicus Brief

Dec 2, 2020 | Jeff Francer

U.S. v. Arthrex

AAM Amicus Brief

May 14, 2020 | Rachel Schwartz

AAM SUPPORTING PETITIONERS ON SEVERABILITY

AAM Amicus Brief

Oct 17, 2018 | Jeff Francer

HELSINN v. TEVA

AAM Amicus Brief

May 21, 2018 | Rachel Schwartz

SAINT REGIS MOHAWK TRIBE and ALLERGAN, INC. v. MYLAN PHARMACEUTICALS, INC ., TEVA PHARMACEUTICALS USA, INC., and AKORN, INC.

AAM Amicus Brief

Jan 26, 2018 | Erica Klinger

PFIZER, INC. v. JOHNSON & JOHNSON and JANSSEN BIOTECH, INC.

AAM Amicus Brief

Dec 1, 2017 | Erica Klinger

MYLAN PHARMACEUTICALS INC., TEVA PHARMACEUTICALS USA, INC., and AKORN INC., Petitioners v. ALLERGAN, INC., Patent Owner

AAM Amicus Brief

Oct 20, 2017 | Erica Klinger

OIL STATES ENERGY SERVICES, LLC, PETITIONER v. GREENE’S ENERGY GROUP, LLC, ET AL.

AAM Amicus Brief

Sep 5, 2017 | Erica Klinger

AMGEN INC., AMGEN MANUFACTURING LIMITED v. SANDOZ INC.

AAM Amicus Brief

Jul 10, 2017 | Erica Klinger

MOMENTA PHARMACEUTICALS, INC. v. BRISTOL-MYERS SQUIBB COMPANY

AAM Amicus Brief

Feb 6, 2017 | Erica Klinger

TC HEARTLAND, LLC D/B/A HEARTLAND FOOD PRODUCTS GROUP v. KRAFT FOODS GROUP BRANDS LLC